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Antimicrobial Therapy for Otitis Media
With Effusion ('Secretory' Otitis Media)
Erdem I. Cantekin, PhD; Timothy W. McGuire, PhD; Terri L. Griffith , PhD

Objective.- To determine the effectiveness of antimicrobial treatment for
otitis media with effusion ("secretory" otitis media) in children.
Data Source.-We report the reexamination of a previously published study
by Mandel et al that evaluated the efficacy of a 2-week course of antimicrobials
(amoxicillin trihydrate) with and without a 4-week course of an oral decongestantantihistamine combination in a double-blind , placebo-controlled, randomized
trial involving 518 infants and children with otitis media with effusion.
Data Synthesis.-At 4 weeks , amoxicillin efficacy as determined by a tympanometric criterion (P = .121) or by a measure of improvement in hearing
(P = .311) was insignificant. Only by otoscopic judgment, which is shown to
contain a systematic bias as used in this clinical trial, could an argument be
made for a marginal efficacy of amoxicillin at the 4-week end point. Logistic regression analyses of the combined effects of treatment and prognostic factors
showed no significant differences between placebo- and antibiotic-treated
groups for unilateral effusions and for bilateral effusions. When subjects with
unilateral and bilateral effusions were combined , the estimated efficacy of antibiotic treatment was 12.3% by otoscopy (P= .014) and 4.8% by tympanometry (P = .171) . We also demonstrate the sensitivity of outcome to diagnostic
measures used and provide statistical evidence questioning the validity of otoscopic observations in this study. Six weeks after the termination of amoxicillin
therapy, the recurrence of effusion was two to six times higher in the
amoxicillin-treated children than in those treated with placebo (P = .001 ), and
resolution of effusion was not significantly different among antibiotic and
placebo groups (1 3.6% and 11.3%, respectively; P = .477).
Conclusions.-Amoxicillin with and without decongestant-antihistamine
combination is not effective for the treatment of persistent asymptomatic
middle-ear effusions in infants and children .
(JAMA. 1991;266:3309-3317)
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IN CURRENT medical practice, nonsurgical treatment of otitis media with
effusion ("secretory" otitis media) is limited to few choices. 1 Antibiotics with
and without decongestant-antihistamine
combination are the most commonly used
medications. The lack of efficacy of an
oral decongestant-antihistamine combination for treating this condition in children has been reported. 2 The present

study was conducted at the Otitis Media
Research Center (OMRC) in Children's
Hospital of Pittsburgh, Pa, betweenJuly
1981 and October 1984 to determine the
efficacy of antibiotics with and without
decongestant-antihistamine combination
for otitis media with effusion, using an
experimental design and patient population similar to those in the previously
reported decongestant-antihistamine
trial. Two years after the termination of
the trial, two separate manuscripts with
opposite conclusions were submitted to
the New England Journal of Medicine
(NEJM) in June 1986. The first author
of the present report was a co-principal
For editorial comment see p 3333.

investigator and a coauthor of the earlier drafts of the first manuscript (by
Mandel et al) but had disagreed with its
analysis and conclusions. The first manuscript (the official report of the OMRC),
submitted by Mandel et al, 3 was accepted
and subsequently published by the
NEJM. Our manuscript, however, was
returned without review according to
the NEJM's editorial decision of publishing only the articles submitted by
principal investigators. (This statement
is based on a written communication
[January 6, 1987) from the editor of the
NEJM, Arnold S. Reiman, MD, to Robert L. Potter, JD. Dr Reiman wrote: "The
important question, therefore, is not
whose interpretation is correct . . . but
rather who has the right to publish ... "!)
Since 1986, the efforts of the University
of Pittsburgh and Children's Hospital of
Pittsburgh have been successful in cen-
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soring our manuscript from publication,
as discussed in detail elaewhere.,.~
Since otitia media ia a very common
childhood diiea.ie, and ainct amoxicillin
jg the most frequently prescribed antibiotic for this condition, the results reported by Mandel et al are extremely
important to the medical community and
the public at large. Therefore, we believe it is important to report this reexamination of their results . Usini the
same data set, the analyses presented
herein are substantially different in sev,
eral major aspects from thoie presented
by Mandel et al (eg, multiple outcome
measures are examined, initial differences in prognostic factors among treatment groups are accounted for, recurrence patterns amoni treatment iJ'OUJ>I
are analyzed). Therefore, we think thi,
second publication is warranted.
Today's rationale for usini antimicrobial therapy for otitis media is based on
the following concepts and observations:
(1) the commonly accepted but not
proven hypothesis is that nollluppurative, "secretory" otitis media with effusion is secondary to bacterial infection
of the middle-ear space 6·7 ; (2) the type
and frequency of bacteria recovered from
these effusions are similar to those of
bacteria found in acute middle-ear infectionss. 11 ; (3) current medical practice
for treating acute otitis media is a generous course of antimicrobial3, althouih
the efficacy of this treatment in reaolving effusion wu never eatabliahed in a
placebo-controlled, randomized, doubleblind study, 1~ 16 and the willdom of such
medical manJliement hu been recently
shown to be flawed 1i-!ill; and (4) aome
clinical trials report a varyin&' range of
efficacy of antimicrobial3 to treat otiti1
media with effusion. 21 -30

METHODS
Infants and children from 7 months to
12 years of age who were suspected of
having otitis media with effuiion were
referred to this double-blind, placebocontrolled, randomized clinical trial from
the Ambulatory Care Center of Children's Hospital and from private phy1icians in the community. After the enrollment of 518 children, the clinical trial
was stopped without reachini the oriJinal target sample size of 1040 subject.I
because of an apparent significant di!ference in cure rates between the treatment iJ'OUps. The study population, enrollment procedures, criteria for patient
eligibility, random assignment, drui administration and compliance monitorini,
follow-up observations, and issues related to other clinical procedure• were
described in detail by MAndel et al1 ;
therefore , only a brief summary of the
essentials is provided herein.
1310
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Table 1.- ~ of TrMtment Groupe by Patient Characteristic&•
AB • DA

Aa+PL

P"L+PL

Total

178

168

172

518

23

13

22

58

155

155

150

460

7-23 mo

SIi

53

48

159

2-5 y

71

73

74

218

26

29

28

83

29

25

24

71

26

25

24

75

48

52

52

152

1,2

53

50

155

l!rvolled

lbduclltdt
~
$(rllificalion ¥el\etllN

•

•-12 y
Duration

...
0-3

°'

effution, wk

>I
Unknown

..,...

Previous

anlimicrobiall for lhia epilode

No

M

56

52

162

101

99

98

298

ProerlOltic factor•
Lalerality

°' eflueiont

Unilll&erll
lileltral

Midck-Mr .-istic impedanc-t

'4

64

50

178

t1

91

100

282

0-5.0

«

50

38

132

5.1-7.0

5e

54

54

164

> 7.0

61

48

58

157

4

3

0

7

Not~

Heeringioatll
0-10

1Hl0

10

13

9

32

~

46

43

138

21-30

48

49

48

145

31-40

32

26

34

92

> 40

9

10

8

27

Not IT'IMIU~

7

11

8

26

M

101

102

100

303

F

17

SI

56

171

112

113

11 4

339

43

47

42

135

Other charact.,-istic•~

Sex

"ace

wt-.
MonwNla

Socioeconomic ttalll•
~Olmiodie

'5

81

89

255

~

13

69

81

193

No(__,

10

10

6

26

Winw

12

64

59

185

~

«

49

45

138

Summer
FIii

25

21

17

63

27

26

35

111

102

3

118
39
3

•

18

150

142

13
143

158
2
0

155
4

5-'latenl,y

~-.piralor;-lred ndon al initiel vieit
No

«

't'N

u,.,_,
HiNoryql,,....._ . . . . .
No

Vee
"-'i'I ~
No

Vee
No(1'11C01ded

53

150
6
0

.

331
136
7
39

435
461
12

~ ~

...,.. amoxieillin with ~ t a n t-ilntihistamine combination (All + DA), amoxiciffin with
), and placebo with placebo (PL + L).

~=two_,. placebo (M +

tchildren miMillQ one or mora follow-up visits alter entry were excluded.

tWhtn bcllll ..,. oonlained .«uaion by ~ mathods (tymp¥o()f1letry and Oloscopy), the ch<ld MS classified IS

~ 10 ~ e n t child's middle-Mr impedance measure in arbitrary units

ol ~ IOffllVY.
~ ltW'9lhold ii . . _ Mr for pure-tone ..,erage or &peeCh awareness was used to represent child's
. . . ic. ii ....... ~ IO normal 1-ing level (di HL).

,._. on tie

23

-.1rom ,....,_

3 conMting of patianta who-. evaluated at the 4 - -k visit.
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T~ 2.-0utcome at 4 WNlcs by Oioecopy, by
T y ~ y, and by Change in Hearing Accofding to Treatment Group5 in 480 ChiJdr.ii•
Aa+DA U + l'L l'L + l'L Total
Oloscopyt
Effusion
Acute otitis
Effusion lrN

Tympanometryt
Effu5ioo
Acuteotitis
Effusion frN
Hearingi
Same
Wo<-.a

Sett«

105
112
94
11
12
20
52
411
25
x' - 14.18, af - 4, P - .oos

291
43
126

111
117
117
11
12
20
25
13
26
x'~ 8 .29, df = -4 , P = .081

352
43
64

117
85
83
5
3
5
38
~
43
x' - 2.34, df - 4 , P ~. sn

265 .
13
127

*TrNtment groups were amoxicillin wilh ~
!ant-antihistamine combination (AB + DA), amoxicillin
with placebo (All + Pl), and placebo with placebo
(Pl + Pl).
tEffusion-fr&e w/Ji«;t was defined as both ears being
effusion 1,,,. by otoscopy.
tSubjects with tympanogram tvi- 1, 2, 3, -4, 15, II,
or 1O for both Nlli _ , . claasil~ in the elfusion-frN
group (based on 4511 children wilh tympanometric data).
fFor 405 children, improllement in hearing is baMd
on =imum change in pu,e-tone
or speech
awa<eness threshold from entry to 4-week visit ; it
threshold remained within ± 1OdB, hearing was considered unchanged (_,,.~ and 55 children did not haw
paired observaliona and thus _,e excluded.

..,.,age

The diagnosis of otitis media at entry
and at each subsequent examination WIii\
based on the findings obtained by a "validated" otoscopist (sensitivity 94%, specificity 66%) and on the results of tympanometry (sensitivity 95%, specificity
70%). 31 -36 Over 90% of the otoscopic observations were made by a single observer. Hearin&' acuity was also assessed
by detennining air-conduction and boneconduction thresholds at four frequencies, as well IUl by measuring speech
reception or awareness thresholds.
These audiological testing procedurei;
were described previously in detail. 37
After entry evaluation, subjects were
stratified according to age , duration of
the effusion, and whether an antimicrobial drug had been administered for otitis media during the preceding 60 days .
Within each subgroup, patients were
randomly assigned in blocks of three, in
double-blind fashion , to the amoxicillin
and deconi'estant-antihistamine combination ifOUP, the amoxicillin and placebo group, and the placebo and placebo
group. A liquid suspension of amoxicillin trihydrate (Amoxil, supplied by
Beecham Laboratories, Bristol, Tenn)
was administered in a dosage of 40 mg/
kg per day in three divided doses for 2
weeks. The decongestant-antihistamine
was a liquid preparation of pseudoephedrine hydrochloride and chlorpheniramine maleate (Novafed A syrup,
supplied by Merrell-Dow Pharmaceuticals, Indianapolis, Ind), given at a dosage of 1.0 mg of pseudoephedrine hydrochloride and 0.09 mg of chlorpheniramine maleate per kiloifam of body
weight. The medication was adminiaJAMA, December 18, 1991-Vol 266, No. 23

tered four times daily for 4 weeks. The
corresponding placebos for amoxicillin
and for the deconiestant-antihistamine
were identical in appearance and similar in taste to the active medications.
All medication was dispensed in doubleblind fashion.
The subjects were reexamined approximately 2 weeks after entry and at
the end of 4 weeks. The presence or
absence of middle-ear effusion was determined by otoscopy and by tympanometry. At 4 weeks, hearing acuity
was reassessed in the same manner as
at entry. All observers were blinded
with regard to each subject's treatment
woup. In order to evaluate recurrences,
patients whose middle-ear effusions had
cleared during the 4-week study period
were reexamined approximately 4 weeks
after completion of the study.
Proportions were compared with the
use of x2 statistics. We also used logistic
regression analysis to estimate the effect of antimicrobial therapy while controlling for the differences in prognostic
factors across treatment groups. Average power over the various outcome
~alyses employed was large enough to
detect at the .05 level of significance a
10--percentage-point difference between
the treatment groups with over 90%
power.

RESULTS
,opulation Characteristics
Five hundred eighteen children with
unilateral or bilateral otitis media were
~nrolled, of whom 460 were evaluated
at both 2- and 4-week visits. The remaining 58 children did not return for
either one or both of the follow-up visits
ind thus were excluded from the data
analysis . The distribution of subjects
y.rithin the three randomization strataage, duration of effusion, and previous
administration of antimicrobials-is
:shown in Table 1. Also, the distribution
of prognostic factors and other demoifaphic and clinical characteristics con:sidered to have potential influence on
outcome are depicted .
Outcome at 4 WNks
On completion of the chemotherapy
•t 4 weeks, the middle-ear status was
evaluated by otoscopy, tympanometry,
and audiometric threshold. Table 2
hows that differences between the outcomes in antimicrobial-treated and placebo-treated groups were significant
only when otoscopy was used as the diagnostic measure (P = .005). The differences between treatment groups were
not significant when a tympanometric
criterion for the clearance of middle-ear
effusion was chosen (P - .081). Moreover, 32.8% of children in the placebo

group showed improvement in hearing
between entry and the 4-week visit, in
contrast to 30. 7% of children who had
improved hearing in the two antibiotictreated groups (P = .672). Durini' this
period, 43 children were diagnosed by
otoscopy and by clinical signs and symptoms as having an episode of acute otitis
media. The incidence of acute otitis media was greater in the placebo group
than in the antibiotic groups (13.3% vs
7.1% and 7.7%, respectively; P= .122).
The results presented in Table 2 include 460 patients with bilateral otoscopic and/or bilateral tympanometric .
data during both visits at 2 and 4 weeks.
Regardless of the initial laterality of effusion, only patients with bilateral effusion-free ears at the 4-week visit were
classified in the no-disease category. A
measure of improvement in hearing was
available for children who had either
pure-tone average or speech awareness
thresholds at both entry and 4-week visits. Improvement was defined as a
threshold at least 10 dB lower at4 weeks
than at entry. When bilateral pure-tone
average data were available, the ear
exhibiting maximum improvement wai;
used to represent the improvement in
the child's hearing.
By the study protocol, the principal
outcome was the proportion of children
without effusion at the 4-week visit as
determined by a diagnostic algorithm
based on otoscopic and tympanometric
findings described previously. 32 The observed disparity between the objective
(tympanometry, hearing) and subjective
(otoscopy) measures as shown in Table
2 prompted us to conduct a sensitivity
analysis. We examined the outcome at
4 weeks using the above-mentioned algorithm as well as six other measures to
estimate the efficacy of amoxicillin at
this time point. The sensitivity analysis
in Table 3 reveals that the estimated
efficacy of amoxicillin is relatively inconsequential-7.8% or less-and without statistical significance by all outcome measures that are not heavily influenced by otoscopy. Only for the pure
otoscopy measure and for the algorithm
are the estimated efficacies greater than
10% (16.0% and 11.7%; P= .004 and
P= .027, respectively) if the outcome is
not corrected for the preponderance of
unfavorable prognostic factors for the
placebo group. With correction, the efficacy is 9.1% (P"" .040) using the algorithm.
In this analysis and the ensuing analyses of prognostic factors, we have omitted 43 cases for which acute otitis media
was diagnosed during this 4-week period. Omission of those subjects was
thought to be justified for the following
reasons: (1) the purpose of this study
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Table 3.-Sensitivity Analysis of Outcome at 4 Weeks*
Treatment Groupst

..... .....

AB + DA
(n=144)

AB + PL
(n=142):t

PL + PL
(n=130)

%
Difference

Probability

Otoscopy

36.1§

34.3

19.2

16.011

.004~

Outcome Measure

40

Algorithm#

26.4

24.6

13.9

11.7

.027

Tympanometry

18.1

17.6

10.0

7.8

.121

Otoscopy and tympanometry••

15.3

12.6

8.5

5.5

.225

Normal hearingtt

23.0

20.9

18.0

.611

Hearing improvement:j::j:
Combined criterion§§

27.1

36.0

32.5

3.9
- 1.0

11 .5

9.0

6.6

.108

Hearing loss

.400

Middle-ear acoustic
impedance

.100

Total

Unilateral

.381

BIiaterai

~

Total

.1 00

.748

.002

.001

.062

.014

.004

.669

.463

.015

.534

.019

.171

.034

.933

Estimated antibiotic
efficacy,%

18.3

10.1

12.3

6.8

1.5

4.8

Reduction in efficacy
due to prognostic
factors,%

2.7

1.3

3.7

6.6

2.2

3.0

Sample size:j:

144

246

390§

144

245

389

*Initially, when both ears contained effusion by both methods (tympanometry and otoscopy), the child was
classified as having bilateral effusions.
tP values for logistic regression are shown.
:j:Sample sizes exclude 43 children who developed acute otitis media and 27 children with missing initial data on
either hearing loss or acoustic impedance .
§For otoscopy, an additional subject for whom tympanometric data are missing is included.

was not to estimate the prophylactic efficacy of antimicrobial treatments, (2)
acute otitis media is a common occurrence in this age group that is externally triggered and is not controllable
within the study design, and (3) many of
those children were treated with additional antimicrobials.
Prognostic and Diagnostic Factors in
Relation to Outcome
Certain prognostic factors identified
at the initial visit had significant effects
on a child's status at the 4-week visit.
Hearing loss and acoustic impedance of
the middle ear were strongly associated
with the outcome. The relationships between these two prognostic factors and
cure rate found by otoscopy and tympanometry are illustrated in Fig 1. Large
hearing loss or increased acoustic impedance due to mass loading of the mid3312

die cavity was significantly related to
poor outcome.
Relationships between these prognostic factors and outcome at the 4-week
visit were investigated to identify possible confounding factors. We believed
that it might be important to control for
the combined effect of differences in poor
prognostic factors across treatment
groups, because these factors have significant individual effects on outcome
and because it happened by chance that
in almost every case prognostic factors
were worse for the placebo group than
for the antibiotic-treated groups. For
example, more children in the placebo
group had bilateral effusions at entry
than those in the other groups (66. 7% vs
58.7%).
For the analysis presented in Table 4,
both antibiotic-treated groups were combined, since these two groups showed
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..... .....

.... .....

•

10

u.

.014

Laterality

-...o
.....

0
(1)

C
0

·;;;
2

0

w
J{J

2
4
6
8
Minimum Acoustic Impedance,
Arbitrary Units

10

()
(1)

E:,

50

Cl)

0
~
0

40

''

Otoscopy
,(P<.001)

,1
0

30

'

0

'\.o

''

20

0

''

10

Tympanometry

Bilateral*

.060t

..... ..... 0 0
..... .....
~
.....

20

Table 4.-Logistic Regression Analyses of Combined Effects of Antibiotic Treatment and Prognostic Factors
on Patient Cure Rate by Initial Laterality of Effusion According to Otoscopic and Tympanometric
Measurements

Unilateral

. . . .....!

30

*Excluding 43 children who had developed acute otitis media during the 4-week period.
tGroups were amoxicillin with decongestant-antihistamine (AB + DA), amoxicillin with placebo (AB + PL), and
placebo with placebo (PL + PL).
1:For otoscopy, an additional subject for whom tympanometric data are missing is included.
§Percentage of the treatment group that is effusion free or with normal or improved hearing or both.
IIDifference between the placebo group and the combined antibiotic groups.
~Calculated by x' statistics using three treatment groups and two outcome categories.
#Combination of otoscopy and tympanometry according to the algorithm described in the original study protocol
(reference 32 with tympanogram type 12 with negative otoscopy as indicative of effusion using Bayesian estimates)
and not employed by Mandel et al' in their analyses of outcome.
** Effusion free by both methods (tympanometry and otoscopy).
ttHearing loss in either ear not exceeding 1O dB HL; sample sizes were 139, 134, and 122, respectively.
:j::j:As defined in Table 2; sample sizes were 129, 125, and 114, respectively.
§§Effusion free by both methods and hearing loss in either ear not exceeding 1O dB HL; same sample size as in
footnote tt.

Antibiotic treatment

Otoscopy
(P=.048)

.311

3.7

Otoscopy

..... .....

0

10

20

''

''

30

50

Maximum Hearing Loss, dB HL

Fig 1. - Effect of prognostic factors on cure rate at
4-week visit by otoscopy and by tympanometry: initial middle-ear acoustic impedance (top) and initial
hearing loss (bottom). Data points are the boxcar
average values for one fifth of the sample without
acute otitis cases and lines are the linear regression
fits based on all observations (n = 390) , not just the
five average values plotted.

similar results (see Tables 2 and 3). In
this model the population was split into
two ex ante identifiable subsamples: initial unilateral disease only and initial
bilateral disease only. Curing two ears
is fundamentally different from curing
one ear. Since the observation unit is
the patient, these two subpopulations
exhibit significantly different cure rates.
The differences between cure rates in
the unilateral and bilateral disease are
significant at the .001 level by otoscopy
and the .01 level by tympanometry.
The logistic regression results, which
include the effects of prognostic factors
on the outcome, are summarized in Table 4. At the P :s;; .Ol level, none of the
estimated effects for antibiotics are significant. When tympanometry is used
as the diagnostic measure, the effects of
antimicrobial treatment are insignificant
(P= .100,. 748, and .171) and have small
estimated efficacies (6.8%, 1.5%, and
4.8%) for the unilateral, bilateral, and
pooled samples, respectively. Even
when the algorithm specified in the protocol is used as the diagnostic measure,
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Table 5.-Subject Response Patterns Including 2-,
4-, and 8-Week Visits by Otoscopy and by Tympanometry According to Treatment Group in 460
Children •
AB+DA

AB + PL PL + PL

Total

Otoscopy
Persistence
77
80
90
247
Recurrence
29
22
13
64
Acute otitis
13
16
21
50
Clearance
36
37
26
99
Differences in clearance : x'= 2.33, d/ = 2, P =. 312
Differences in recurrencet : x' = 6.44, di = 2, P = .040
Tympanometry
Persistence
103
98
109
31 O
Recurrence
21
17
3
41
Acute otitis
13
16
21
50 ·
Clearance
18
24
17
59
Differences in clearance: x'= 1.48, d/= 2, P=.477
Differences in recurrencet: x'= 13.74, d/ = 2, P=.001
*Persistence indicates otitis media with effusion during all visits; recurrence, presence of effusion after
clearance at 2- or 4-week visit ; and clearance, effusion
free at last visit or visits without recurrence . By protocol,
only patients without otitis media with effusion at the 4week visit returned for the 8-week visit. Treatment
groups were amoxicillin with decongestant-antihistamine combination (AB + DA), amoxicillin with placebo
(AB + PL), and placebo with placebo (PL + PL).
tRecurrence with respect to the total population .

the estimated efficacy was only 9.1 %
(P = .040). An effect can be demon-

strated only when the unilateral and bilateral disease cases are pooled into a
single combined sample and otoscopy is
used as the diagnostic measure
(P= .014). The estimated antimicrobial
treatment efficacy is 12.3% in this case;
the reduction in efficacy of 3. 7 percentage points (from 16.0%; see Table 3) is;
the result of statistically standardizing
for differences in prognostic factors .
Patient Response Pattern

In this study, subjects who were free
of effusion at the 4-week end point by
otoscopic diagnosis were reexamined approximately 4 weeks later. Taking advantage of this repeated measure in the
study design, we evaluated patterns of
patient response to antimicrobial therapy (which was terminated at 2 weeks)
using 2-, 4-, and 8-week visits. The response patterns are summarized in Table 5. By otoscopic diagnosis, 23.5% of
children treated with amoxicillin and
17.3% of children who had placebo were
disease free during this 6-week interval
(P = .312). Using the tympanometric criterion to define disease-free children,
the antibiotic groups and the placebo
group were very similar (13.6% vs 11.3%;
P= .477). These findings do not support
the hypothesis that antimicrobial treatment might have a beneficial but delayed effect. On the contrary, recurrence
rates were two to six times larger in the
antimicrobial-treated groups than in the
placebo group by otoscopy (P = .040) and
by tympanometry (P= .001), respectively, as shown in Table 5. If the recurrence rates are calculated conditional
on children who were effusion free at
the 2- or 4-week visit, then the recurJAMA. December 18, 1991-Vol 266, No. 23

rence rates by tympanometry were
47.5% for the combined antimicrobialtreated group and 15.0% for the placebo
group (P < .01 ).
Period of Observation,
Compliance, and Side Effects

The actual interval between entry into
the trial and evaluation at 4 weeks- the
period of observation-and compliance
with medication requirements are discussed in detail in the report by Mandel
et al. 3 These two parameters were not
related to outcome, and the differences
with respect to compliance and period of
observation were insignifi'cant among
the treat ment groups.
Commonly reported side effects by
parents were mild sedation or irritation, with occasional incidence of diarrhea and rash. In the antibiotic-treated
groups, these side effects were reported
in 15% of the children who were also
treated with decongestant-antihistamine
combination and in 9% of those children
t reated with amoxicillin alone. In the
placebo-treated group, side effects were
reported for 6% of the children.
COMMENT
Comparison With Study by
Mandel et al, 1987

The present report, based on reexamination of the database of the clinical
trial reported by Mandel et al,3 reveals
opposite conclusions, ie, lack of efficacy
of amoxicillin for treatment of otitis media with effusion in children. The purported efficacy of amoxicillin could not
be demonstrated by our analysis of the
same data. Our presentation of the data
from this clinical trial contradicts as well
as augments the information disseminated by the report by Mandel et al in
several aspects.
Mandel et al base their primary r esults and conclusions on the proportion
of children determined to be effusion
free at 4 weeks by the combination of
otoscopic and tympanometric findings
using an algorithm cited in the "Methods" section of their study. 33 The algorithm Mandel et al employed is, however, not the algorithm described in the
original study protocol32•33 ; it is not validated based on some "gold" standard
such as myringotomy34; and it is an algorithm in which over 90% of the decisions are based on the subjective measure of otoscopy alone. 34
We attempted to replicate the primary end-point findings of Mandel et al
using the method they describe to assess middle-ear status; however, we
were unable to do so. In the NEJM
article (Table 2), Mandel et al show 118
children as "cured" at the 4-week visit.
Applying conservatively the algorithm

they claimed they have used, we found
only 88 "cured" children at the 4-week
visit. (For example, in 12 cases, when
the algorithm required the acoustic reflex measurement to determine the outcome, those measures for r eflex were
missing. This is a condition where otoscopy was recorded to find the ear effusion free, with a tympanogram type 12
associated with a .91 probability of effusion for the same ear. These 12 cases
were counted as "cured" by Mandel et
al, notwithstanding t he high probability
of effusion by tympanometry. In 16 other
cases with positive tympanometry and
negative otoscopy, middle-ear status deteriorated from the initial visit to the
4-week visit, but those patients were
also counted as "cured" by Mandel et
al.) If the statistical analysis of Mandel
et al in the NEJM article is applied to
88 "cured" children, amoxicillin's efficacy is reduced from 16.1% to 10.5%,
and the significance of the P value diminishes from P < .001 to P = .05.
Our results using otoscopy alone are
in agreement with the conclusions of
Mandel et al. Our sensitivity analysis
shown in Table 3 demonstrates that only
with otoscopy can an argument be made
about a statistically significant antibiotic efficacy. Other combinations to measure outcome, including the original
study protocol algorithm, show either
marginal or insignificant differences.
Further examination of the outcome at
4 weeks via logistic regression analysis
reveals t hat prognostic factors have a
significant effect on the results (Table
4); correcting statistically for these differences in prognostic factors reduces
estimated efficacy by 1.3 to 6.6 percentage points. The role of initial hearini
loss and acoustic impedance on the outcome, not examined by Mandel et al,
shows that the differences in cure rate
between antibiotic and placebo groups
are further reduced when those prognostic factors are included. After this
adjustment, even with otoscopic results,
the estimated antibiotic efficacy is reduced from 16.0% to 12.3%.
In addition to the 4-week outcome,
we also have included an analysis of patient response patterns based on all data
from 2-, 4-, and 8-week visits (Table 5).
This section also addresses the recurrence issue and concludes that children
treated with amoxicillin had more recurrences than children who received
placebo within a 6-week period after termination of the antimicrobial therapy.
The r eport by Mandel et al does not
expose the fact that there is a recurrence problem with amoxicillin-treated
children that is greater than the recurrence found in placebo-treated children.
Mandel et al also fail to mention that,
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even with otoscopic measure, there were
no statistically significant differences
among t he tr eatment groups with respect to children who remained effusion
free at the 8-week visit.
Comparison With Other OMRC
Studies

Following the early termination of this
clinical trial with only one half of the
target sample size, the OMRC between
1984 and 1987 conducted the second
phase of this study using the same design but with four treatment arms. The
OMR C kept the placebo and amoxicillin
groups but added two additional antibiotic groups, Pediazole (erythromycin,
ethylsuccinate-sulfisoxazole) and cefaclor, for the second clinical trial. Once
again, the OMRC terminated the clinical trial without reaching the target
sample size, when the OMRC discovered that the placebo group and the three
antibiotic-treated groups had virtually
the same cure rates at the 4-week end
point. 'ix With a sample size of 310 subjects, cure rates were 26. 7%, 29. 9%,
25.0%, and 33.3% for placebo-, amoxicillin-, Pecliazole-, and cefaclor-treated
groups, respectively. '1~
At the time of the publication of the
study by Mandel et al in the N EJM in
February 1987, the OMRC was in possession of those second-phase data, and
those data indicate that amoxicillin was
not effective and that two other antibiotics, Pediazole and cefaclor, also were
not effective according to the method of
analysis the OMRC had chosen to use.:ix.:ir,
Nevertheless, the OMRC published the
report by Mandel et al in the NEJM,
knowing that t he second-phase data did
not support but contradicted the conclusions of the report by Mandel et al.
The results of the second phase have
never been published.
A curious result in the report by Mandel et al is the 4-week cure rate (14.1 %)
for the placebo control group. It was
significantly less than those encountered
in an earlier study of the OMRC (decongestant-antihistamine) and in the second phase of the antibiotic trial (24.0%
and 26. 7%, r espectively; P =. 022). Between 1981 and 1987, the OMRC completed three randomized, placebo-controlled clinical trials evaluating the efficacy of decongestant-antihistamines
and antibiotics for otitis media with effusion with 4-week sample sizes of 553,
474, and 310, respectively. Those trials
had nine treatment groups with the following 4-week cure rates: 24.0%, 14.1%,
and 26. 7% (for the three placebo groups);
and 24. 5%, 28.8%, 31.6%, 29.9%, 25.0%,
and 33.3% (for t he six active treatment
groups). Among those nine groups, only
the placebo group in the report by Man-

de! et al is strikingly different (P = .018).
This anomalous cure rate in the placebo group, however , is not discussed
by Mandel et al. We speculate t hat it is
t he result of a preponderance of poor
prognostic factors in that placebo group
(more bilateral disease, larger hearing
losses, higher acoustic impedance values). Such a malclistribution of prognostic factors can result from either improper randomization or other problems
related to group assignments. Mandel
et al neither try to explain nor statistically correct for this problem.
Between January 1984 and May 1985,
the OMRC conducted another clinical
trial to evaluate the relative effectiveness of a new antibiotic, Augmentin
(amoxicillin trihyclrate-clavulanate combination), in comparison to amoxicillin
for otitis media with effusion. This clinical trial also was patterned after the
report of Mandel et al but without a
placebo control group. The study subjects were enrolled and evaluated by
t wo private pediatric practice groups
outside Children's Hospital of Pittsburgh
on a fee-for-subject basis arrangement.
This trial was supported by the manufacturer of the new antibiotic.
The findings of this clinical t rial involving 108 children were published by
the OMRC in 1988, with Chan et al28
concluding that both antibiotics (Augmentin and amoxicillin) were equally effective . According to Chan et al, the
cure rate for amoxicillin-treated subjects
at the 4-week encl point was 51.5%. This
result was significantly better than the
28.8% cure rate reported for the amoxicillin-treatecl group by Mandel et al,
who used the identical method of analysis. Chan et al inexplicably fail to mention this significant difference (P = . 005)
between the two amoxicillin-treatecl
groups. When the 4-week encl point in
the study by Chan et al is evaluated
using tympanometric results, however,
the studies by Chan et al and Mandel et
al yield almost identical cure rates (19.2%
vs 17.6%). This discrepancy between the
subj ective measurements (otoscopy) and
objective measurements (tympanometry) illustrates nicely the clangers in r elying on subjective measurements to define the outcome of non-placebo-controlled clinical trials. The otoscopists in
the study by Chan et al knew t hat both
groups were receiving antibiotics and
managed to see "cures" almost twice as
frequently as the otoscopists in the study
by Mandel et al and almost three times
as frequently as tympanometric cure
rates.
Bias in Otoscopy

One of the most puzzling aspects of
the present findings was the difference
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in results by otoscopy and by tympanometry . In a study published by Maw
and Herod, 40 no such significant difference appears. In the present study, however, twice as many children were
judged to be effusion free at the 4-week
visit by otoscopy as by tympanometry
(27.4% vs 13.9%; P < .001 ).
The difference in cure rates between
the treatment groups (efficacy) is shown
in Table 3 for various outcome measures
(sensitivity analysis). Efficacies as determined by otoscopy and by tympa·
nometry were 16.0% and 7.8%, respectively. When the entry imbalance of
prognostic factors is corrected for, those
figures are further reduced to 12.3CJ
and 4.8% (Table 4). The overlap in efficacy between otoscopy and tympanometry was 5.5% (Table 3, row 4 and column 4) , resulting in 18.3% and 5.iio/c
upper and lower bounds. These values
are reduced to 13.3% and 3.8% when
corrections for prognostic factors are
included.
We hypothesized that the dispa1ity
between otoscopic and tympanomet1ic
results could be explained in part by the
fact that the otoscopist observed both
ears before recording t he r esults. This
knowledge, we hypot hesized, might well
bias the otoscopist in the direction of
judging both ears the same. The tympanometry, of course, could not have
that bias.
The probability of effusion associated
with a given tympanogram is well known
from prior work. 34 If otoscopy measures
were unbiased, one would expect the
proportion of ears that are judged to
have effusion by otoscopy not to be different from the known tympanomet1ic
probability of effusion. In other words.
for a given tympanogram type, the difference bet ween the proportions of ears
found to have effusion by otoscopy and
by tympanometric probability of effusion should be zero on the average. The
top frame in Fig 2 shows this difference
in probability (vertical axis) plotted
against the tympanometric probability
of effusion (horizontal axis) fo r two conditions: (1) other ear without effusion
(solid circles) and (2) other ear with effusion (open circles). In the absence of
bias, both of these plots should fluctuate
randomly around a line of zero difference. However , for every tympanogram
type, the probability that the otoscopist
would find effusion in one ear was greatly
influenced by the otoscopic findings of
the other ear. Figure 2 (top frame, solid
circles) shows that where the otoscopist
found no effusion in one ear, the otoscopist scored the second ear at a lower
probability of effusion than the unbiased probability associated with the
given tympanogram type for t hat other
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Table 6. - Effects of Observer Expectations on Otoscopic Decision Making
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Fig 2. - Top, Probability of effusion associated with
a given tympanogram type (P,) and difference
between this tympanometric probability and conditional probability of effusion by otoscopy (P, - Pc)
at 4-week visit. Open circles are conditional probability differences from tympanometric probabilities
given that the "other" ear has effusion (P~); filled
circles are for the "other" ear being without effusion
(P~)- Numbers in circles indicate tympanogram
types. Data are plotted for tympanogram types with
more than 10 observations. Bottom, The relationship between P, and the difference in conditional
probabilities by otoscopy when the "other" ear is
with and without effusion (P! - P~)-

ear warranted. Similarly, where the
otoscopist had scored the first ear with
effusion, the otoscopist scored the other
ear at a higher probability of effusion
than the tympanogram warranted (open
circles). The two-sidedness of this result is strong evidence that there is indeed a bias in otoscopy arising from the
otoscopist's simultaneous knowledge of
the status of both ears (P<.001).
We also tested to see if otoscopy was
influenced by tympanogram type. Although in the design of the experiment
it was intended that the otoscopist be
blind to the tympanogram type, in fact
in practice the otoscopist frequently
knew the outcome oftympanometry before recording the otoscopic findings .
The bottom frame in Fig 2 shows that
the magnitude of otoscopic bias (see preceding paragraph) varies with tympanogram type, being larger for ambiguous
tympanograms (such as types 7 and 14,
with effusion probabilities of 0.38 and
0.47, respectively) and smaller for tympanograms of greater certainty (such as
types 1, 4, 9, 12, and 13). This effect is
significant (P = .008).
We have thus demonstrated that there
JAMA, December 18, 1991 -Vol 266, No. 23

is a systematic bias in otoscopy arising
from at least two factors: (1) the otoscopist's simultaneous knowledge of the
condition of both ears before recording
and (2) the otoscopist's knowledge of
the tympanogram type.
We also investigated the relationship
between the curing of ears vs the curing
of patients with bilateral disease. Efficacies (difference between the placebo
and the antibiotic groups) for ears alone
were very similar by otoscopy and tympanometry (9. 9% vs 7.2%, respectively).
Significant differences in efficacies between otoscopy and tympanometry appeared when the patient was the experimental unit (11.4% vs 3. 7%). For
otoscopy, the efficacy for patients is
11.4%, which is 15% larger than the 9.9%
efficacy for ears. This is a most curious
and unlikely result. If there were a perfect correlation between curing ears and
curing patients (every patient with bilateral disease in whom one ear was
cured was also a patient in whom both
ears were cured), then the efficacy of
curing ears and the efficacy of curing
patients would be the same. One would
expect, however, that the efficacy for
curing ears is always higher than that
for curing patients (because of the presence of patients with bilateral disease
who had clearance in only one ear). It is
not logically possible to have the patient
efficacy rate higher than that for ears
alone. For tympanometry, the patient
efficacy rate is 3. 7%, which is lower than
the ear efficacy of7.2%. There is, therefore, sound reason to be suspicious of
the otoscopic data produced by this experiment.
Observer Expectations
Biasing Otoscopy

We also investigated the possible confounding effects of other observer ex-

pectations on the outcome. Since the
tympanometric method is essentially a
machine-made recording, we assumed
that it would not be influenced by observer expectations. Also, the tympanogram patterns used in the diagnostic
decision making were externally validated. Using the coherence (agreement
or disagreement) between the two methods of diagnosis as the measure, we
tested three elementary hypotheses concerning observer expectations: (1) middle-ear effusions resolve after some time;
(2) medically treated children will do
better than untreated children; and (3)
if the observer sees one effusion-free
ear first, chances of finding a contralateral effusion-free ear are higher.
The findings of this investigation are
shown in Table 6. All the above three
factors demonstrated significantly different coherence values between the two
methods, suggesting a strong observer
expectation effect. The time effect on
observer expectations is illustrated in
the first panel. At entry to the study,
the two methods were almost in total
agreement (coherence, 99%); however,
by 2 weeks, agreement was only 80%
(P< .001). The second panel shows the
effect of treatment assignment on observer expectations. At 4 weeks, coherence for the placebo-treated group was
88%, which was significantly higher than
coherence values for the two antibiotictreated groups (P = .012). Although the
observers were blinded to treatment assignments, some unknown factors such
as reported side effects or conversations
with parents might have induced clues
about the assignment, thus influencing
the observer. The presence of a single
disease-free ear is more likely to produce an otoscopic deci,;ion of a diseasefree child. The third panel in Table 6
shows that in unilateral effusion (by tym-
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panometry) the coherence between t he
two measures was 70%, which was significantly different from the coherence
when subj ects had either bilateral effusions or bilateral effusion-free ears
(P = .001).
Another problem associated with otoscopic findings is the cure rate difference between placebo- and antibiotictreated groups in unilateral disease that
exceeds the possible physiologic upper
bound. The most plausible mode of action of antimicrobials in resolving secretory otitis media is the sterilization of
effusion from pathogenic bacteria. Although it is not documented, if sterilization and clearance are related, t hen it
may be possible to estimate the maximum efficacy of amoxicillin and to determine the upper bound for cure-rate
differences between placebo-treated and
antimicrobial-treated groups.
It was reported that H aemophilus influenzae and Streptococcus pneumoniae,
the two amoxicillin-sensitive pathogenic
bacteria, were isolated in 16% of t he
effusions from ears with secretory otitis
media. 11 Also, it has been shown t hat
amoxicillin is 83% effi cient in eradicating these two species of microorganism
in acute otitis media. 13 Using t hese two
figures, the upper bound or the maximum differences between the two treatment groups would be about 13% when
ears are used as the experimental unit
if the sterilization concept is the only
operative mechanism.
According to tympanometric findings,
the ear-based cure-rate differences
among t he placebo and amoxicillin
groups were 7.2% for bilateral disease
and 13.5% for unilateral disease, which
is within t he limits of the hypothesis of
pathogenic bacteria eradication. However, by otoscopic results, the differences were 9.5% for bilateral disease
and 15. 7% for unilateral disease. Therefore , otoscopic findings for children with
unilateral disease who were treated with
amoxicillin are beyond this upper bound
and not possible to explain by this hypothesis - sterilization of the effu sion.
These observations support our argument that the tympanometric results
are more valid than the otoscopic findings and t hat otoscopy as employed in
this study has a systematic bias. Furthermore, the arguments and evidence
provided above suggest that estimates
of antibiotic efficacy by otoscopy for the
bilateral effusions cannot be valid, and
estimates for the unilateral disease are
an unlikely physiologic possibility.
Therefore, averaging of the otoscopic
and tympanometric measures is unlikely
to contribute to our understanding of
the efficacy ofantibiotics. It is our judgment that science is better served by
3316

the exclusion of the present otoscopic
results.
Comparison With Other Studies

The children treated with amoxicillin
in the present study had less frequent
resolution of effusion at 4 weeks than
t he values reported by other uncontrolled clinical trials evaluating the effi cacy of various antimicrobials for otitis
media with effusion.21 -26 With the exception of the OMRC clinical trials, comparison of the present findings with other
studies will be difficult since t he diagnostic accuracy, measures for outcome,
patient selection criteria, study design,
choice of antibiotics, and duration of
treatment were all different between
t he studies. Furthermore, none of the
previous studies used a placebo-controlled, double-blind , randomized study
design with a large cohort of subjects to
balance the distribution of prognostic
factors. Five of the six previous reports
demonstrating significant benefit of antimicrobial treatment (cure rate range,
45% to 65%) did not include a placebo
control group, and the only study with
a placebo group used a nasal decongestant treatment as placebo and was limited to 51 subjects. 21 As demonstrated
in Tables 3 and 4, even in a large randomized study like t he present one, the
combined effects of treatment, diagnostic accuracy, and prognostic factors must
be analyzed very carefully before reaching efficacy conclusions.
In two recent placebo-controlled clinical trials, it was claimed that antibiotics are effective in t he treatment of childhood secretory otitis media. Thomsen
et al 29 concluded in 1989 that a 1-month
course of Augmentin (amoxicillin with
clavulanate) is effective for the treatment ofotitis media. One ofus (E. I. C.)
has already published a critical examination of this article, 41 questioning the
conclusion of Thomsen et al on Augmentin efficacy for otitis media with effusion. Otten and Grote30 reported in
1990 t hat a 10-day amoxicillin therapy is
efficacious for otitis media with effusion
in children with concurrent chronic rhinosinusitis. However, their published
(refereed) article shows that after
6 weeks of follow-up the amoxicillin-and
placebo-treated groups had cure rates
of 5.3% and 7.9%, respectively. This is
a curious result considering the efficacy
conclusions of the authors.
CONCLUSIONS

Of t he seven different measures of
outcome, otoscopy, notwithstanding the
questions about its validity, was the only
measure t hat showed significant differences favoring the antibiotic-treated
group at the 4-week visit. Outcome, as
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measured by the remaining six methods
including tympanometry, combination
oftympanometry with otoscopy, and improvement in hearing, was equivocal.
Furthermore, recurrence rates were significantly higher in the antibiotic-treated
group than in the placebo group. Six
weeks after antibiotic treatment, the
number of children without effusion was
about the same in each group. We conclude, therefore, that amoxicillin is not
effective for the treatment of persistent
asymptomatic middle-ear effusions.
Recent publications indicate that antimicrobial treatment is not effective
even for acute otitis media. 14- 19 Our reexamination of the study by Mandel et
al is consistent with those recent findings-ineffectiveness of antibiotic treatment for acute otitis media. Our results
also confirm the conclusions of t he previously reported lack of efficacy of a
decongestant-antihistamine combination
for otitis media with effusion. 2
This study was supported in part by the National
Institute of Neu rological and Communicative Disorders and Stroke, National Institutes of Health
(grant NS-16337), Bethesda, Md .
We acknowledge the Otitis Media Research
Center and its personnel in the conduct of this
study; Joel B. Greenhouse, PhD , and the late Morris H. DeGroot, PhD, for their comments on the
statistical analysis; and Anita Brostoff and Thomas
P. Masley for assistance in t he preparation of early
drafts (5 years ago) and Bonnie J. Schultz for
assistance in the preparation of the present draft of
the manuscript.

References
1. Bluestone CD. Otitis media in children: to treat
or not to treat? N Engl J Med. 1982;306: 1339-1404.
2. Cantekin EI, Mandel EM, Bluestone CD, et al.
Lack of efficacy of a decongestant-antihistamine
combination for otitis media with effusion ('secretory' otitis media) in children: results of a doubleblind, randomized trial. N EnglJ Med. 1983;308:297301.
3. Mandel EM , Rockette HE , Bluestone CD , Paradise JL , Nozza RJ. Efficacy of amoxicillin with
and without decongestant-anti histamine for otitis
media with effusion in children: results of a doubleblind, randomized tiial. N Engl J Med. 1987;316:432437.
4. Cantekin EI, McGuire TW, Potter RL . Biomedical information , peer review, and conflict of interest as they influence public health. JAMA.
1990;263: 1427-1430.
5. Are Scientific Misconduct and Conflicts of Interest Ha zardous to Our Health? 19th Report by the
House Committee on Government Operations.
Washington , DC: US House of Representatives:
1990:28-37. House Report 101-688.
6. Bluestone CD, Klein JO. Otitis media with effusio n, atelectasis, and eustachian tube dysfunction . In: Bluestone CD, Stool SE, eds . Pediatric
Otolaryngology. Philadelphia, Pa: WB Saunders
Co; 1983:356-512.
7. Wheeler MTK. Tympanometry in children with
treated acute otitis media. Lancet. 1986;1:529-532.
8. Liu YS, Lang R, Lim DJ , Birck HG. Microorganisms in chronic otitis media with effusion. Ann
Otol Rhino/ Laryngol. 1976;25(suppl):245-249.
9. Healy GB , Teele OW. The microbiology of chronic
middle-ear effusions in children. Laryngoscope
1977;87: 1472-1478.
10. Riding KH , Bluestone CD, Michaels RH.
Cantekin EI , Doyle WJ , Poziviak CS. Microbiology
of recurrent and chronic otitis media with effusion.

Antimicrobial Therapy for Otitis Media - Cantekin et al

J Pediatr. 1978;93:739-743.
11. Rohn DD, Vatman F, Cantekin EI. Incidence
oforganisms in otitis media. Ann Otol Rhi1wl Laryngol. 1982;92(suppl 107):17.
12. Paradise JL, Rogers KD. On otitis media, child
development, and tympanostomy tubes: new answers or old questions? Pediatrics . 1986;77:88-92.
13. Howie VM , Dillard R, Lawrence B. In vivo
sensitivity test in otitis media: efficacy of antibiotics. Pediatrics. 1985;75:8-13.
14. Van Buchem FL, Dunk JMM, van't Hof MA.
Therapy of acute otit is media: myiingotomy, antibiotics or neither? Lancet. 1981;2:883-887.
15. Mygind N, Meistrup-Larsen KI , Thomsen J ,
Thomsen VF, Josefsson K, Sorensen H. Penicillin
in acute otitis: a double-blind placebo-controlled
trial. Clin Otolaryngol. 1981;6:5-13.
16. Van Buchem FL, Peeters MF , van't Hof MA.
Acute otitis media: a new treatment strategy. BMJ.
1985;290: 1033-1037.
17. Thalin A, Densert 0, Larsson A, Lyden E,
Ripa T. Is penicillin necessary in the treatment of
acute otitis media? Proceedings of the International
Conference on Acute and Secretory Otitis Media.
Amsterdam , the Netherlands: Kugler Publications;
1986:441-446.
18. Ostfeld E , Segal J , Kaufstein M, Gelernter I.
Management of acute otitis media without primary
administration of systemic antimicrobial agents.
Proceedings of the Fourth International Symposium on Recent Advances in Otitis Media. Burlington, Ontario: BC Decker Inc; 1988:235-239.
19. FroomJ, Culpepper L, Grob P, eta!. Diagnosis
and antibiotic treatment of acute otitis media: report from International Primary Care Network.
BMJ. 1990;300:582-586.
20. Browning GG. Childhood otalgia: acute otitis
media: antibiotics not necessary in most cases. BMJ.
!990;300:1005-1007.
21. Marks NJ, Mills RP, Shaheen OH. A controlled
trial of co-trimoxazole therapy in serous otitis media. J Laryngol Otol . 1981;95:1003-1009.

JAMA, December 18, 1991 -Vol 266, No. 23

22. Ernstson S, Sundberg L. Erythromycin in the
treatment of otitis media with effusion (OME). J
Laryngol Otol. 1984;98:767-769.
23. Sundberg L. Antibiotic treatment of secretory
otitis media. Acta Otolaryngol. !984;suppl 407:2629.
24 . Healy GB. Antimicrobial therapy of chronic
otitis media with effusion. Int J Pediatr Otorhi1Wlaryngol . 1984;8:13-17.
25. Ernstson S, Anar M. Cefaclor in the treatment
of otitis media with effusion. Acta Otolaryngol .
1985;suppl 424:17-21.
26. Gates GA, Wachtendorf C, Holt R, Hearne
EM. Medical treatment of chronic otitis media with
effu sion (secretory otitis media). Otolaryngol Head
Neck Surg. !986;94:350-354.
27. Corwin MJ , Weiner LB , Daniels D. Efficacy of
oral antibiotics for the treatment of persistent otitis media with effusion. Int J Pediatr Otorhi1Wlaryngol . 1986;11:109-112.
28. Chan KH , Mandel EM, Rockette HE, et al. A
comparative study of amoxicillin-clavulanate and
amoxicillin: treatment of otitis media with effusion.
Arch Otolaryngol Head Neck Surg. !988;114:142146.
.
29. Thomsen J, Sederberg-Olsen J , Ball~, V,
Vejlsgaard R, Stangerup SE, Bondesson G. Antibiotic treatment of children with secretory otitis
media: a randomized, double-blind, placebo-controlled study. Arch Otolaryngol Head N eck Surg.
1989; 115:447-451.
30. Otten FW, GroteJJ . Otitis media with effusion
and chronic upper respiratory tract infection in
children: a randomized, placebo-controlled clinical
study. Laryngoscope. !990;110:627-633.
31. Bluestone CD, Cantekin EI. Design factors in
the characte1ization and identification of otitis media and ce1tain related conditions. Ann Oto/ Rhi1Wl
Laryngol. !979;88(suppl 60): 13-28.
32. Cantekin El , Bluestone CD, Fria TJ , Stool
SE, Beery QC , Sabo DL. Identification of otitis
media with effusion in children. A nn Otol Rhino/

Laryngol. 1980;89(suppl 68): 190-195.
33. Cantekin EI. Algorithm for diagnosis of otitis
media with effusion. Ann Otol Rhi1Wl Laryngol.
!983;92(suppl 107):6.
34. Brostoff LM , Cantekin EI. Observer invariant
diagnosis of middle ear effusions. Proceedings of
the Fourth International Symposium on Recent
Advances in Otitis Media. Burlington, Ontario: BC
Decker Inc; 1988:47-49.
35. Gates GA, Avery C, Cooper JC, Hearne EM,
Holt GR. Predictive value oftympanometry in middle effusion. A nn Otol Rhi1Wl Laryngol. 1986;95:4650.
36. Wright PF, McConnell KB, Thompson JM,
Vaughn WK, Sell SH. A longitudinal study of the
detection of otitis media in the first two years of
life. Int J Pediatr Otorhi1Wlaryngol. !985;10:245252.
37. Fria TJ, Cantekin El , Eichler JA. Hearing
acuity of children wit h otitis media with effusion.
Arch Otolaryngol. !985;111:10-16.
38. Federal Response to Misconduct in Science:
Are Conflicts of Interest Hazardous to Our Health?
Washington, DC: US House of Representatives;
1988:248. Hearing before the Human Resource~
and Intergovernmental Relations Subcommittee of
the House Committee on Government Operations,
100th Cong, 2nd Sess.
39. Is Science for Sale? Conflicts of Interest vs the
Public Interest. Washington, DC: US House of
Representatives; 1989:214, 217. Hearing before t~e
Human Resources and Intergovernmental Relations Subcommittee of the House Committee on
Government Operations, 101st Cong, ! st Sess.
40. Maw RA, Herod F. Otoscopic, impedance, and
audiometric findings in glue ear treated by adenoidectomy and tonsillectomy: a prospective randomized study. Lancet. 1986;1:1399-1402.
41. Cantekin EI. Antibiotics for secretory otitis
media. Arch Otolaryngol Head Neck Swrg.
1990;I 16:626-628.

Antimicrobial Therapy for Otitis Media-Cantekin et al

3317

